Luoxin Pharmaceuticals Group Stock Co., Ltd.

SZSE:002793.SZ

5.28 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011
Operating Activities:
Net Income -661.138-1,257.986421.646342.601653.755111.346115.852100.36381.78763.95945.96453.66632.521
Depreciation & Amortization 222.542231.306199.777170.598154.76223.44521.15915.42910.0648.4028.1724.7950
Deferred Income Tax 137.323-265.076-57.61410.309-38.996-40.9820.0670.11700000
Stock Based Compensation 00-5.5645.564000000000
Change In Working Capital 621.683-9.104-721.163-703.723-789.955-22.219-46.354-29.356-40.838-44.554-0.133-116.640
Accounts Receivables 791.712689.644-733.092-483.783-1,023.49-370.67-45.8926.933-196.655-46.537.537-80.8540
Inventory 168.467-52.036-70.36870.787-4.171-18.289-32.919-48.892-17.125-23.20112.871-35.7860
Accounts Payables -365.763-381.635139.911-300.332276.703-35.47732.39112.48600000
Other Working Capital 27.266-265.076-57.6149.605-38.996-3.93-13.43419.536-23.713-21.353-13.00400
Other Non Cash Items 83.04996.657283.551142.25397.7681.54311.618-13.6947.10914.02410.752-53.666-32.521
Operating Cash Flow 552.791-939.127120.633-32.398116.33114.115102.27572.74258.12341.83164.75233.31546.532
Investing Activities:
Investments In Property Plant And Equipment -242.39-194.82-309.029-360.76-580.582-187.874-161.067-71.005-41.731-55.584-19.483-80.96-23.309
Acquisitions Net 42.284-1.928-4.58222.741-320-309.780.0010.090.0330000
Purchases Of Investments -24-76.928-137.716-139.322-1,407.64-1000-10000000
Sales Maturities Of Investments 36.971146.07956.524631.5771,532.8152.932104.00410.76903.6783.061.4930
Other Investing Activites 1,094.0938.415-33.618-46.29627.659309.9792.2312.7660.0330.0060.099-80.960.345
Investing Cash Flow 906.959-119.182-428.422107.941-747.749-284.744-54.832-157.38-41.698-51.901-16.324-79.468-22.964
Financing Activities:
Debt Repayment -2,233.21-2,246.627-847.372-775.006-478.693-72.395-91.335-195.559-128.457-111.908-178.641-31.472-63.065
Common Stock Issued 040.6630.1390000000000
Common Stock Repurchased 0-40.66-30.1390000000000
Dividends Paid -76.785-14.947-54.85-72.355-59.509-21.36-60.661-2.458-61.389-1.991-2.982-6.925-25.428
Other Financing Activities 532.5092,769.871,769.2371,041.8011,153.811458.84891.335353.474196.332120.856126.12184.714109.687
Financing Cash Flow -1,716.343384.978789.533130.708615.609365.093-60.661155.4576.4856.958-55.50246.31721.194
Other Information:
Effect Of Forex Changes On Cash 2.1814.099-1.132-19.2995.3992.242-3.194-2.6611.3860.592-4.356-0.829-0.792
Net Change In Cash -740.906-659.232480.612186.952-10.41196.707-16.41268.15824.296-2.519-11.43-0.66543.97
Cash At End Of Period 692.899834.3551,493.5871,012.891825.939319.433122.726139.13870.9846.68449.20360.63361.298